BiSTC Portfolio - Completed Trials

BiSTC trials portfolio  - our completed trials are listed below.  Please follow the hyperlinks to the specific trials websites which contain further information about each study, who to contact and any publications arising from the research.

Table of completed trials in the BiSTC portfolio
BILCAP-Logo-100 pixels wide

BILCAP: A randomised clinical trial evaluating adjuvant chemotherapy with capecitabine compared to expectant treatment alone following surgery for biliary tract cancer

Speciality: Upper GI

Chief Investigator: Professor John Primrose

Funded By: CRUK    Portfolio Study ID: 1473

Phase: Phase III     

Initial Target Number of Patients: 410


FIAT:  The Fistula-In-Ano Trial comparing Surgisis® anal fistula plug versus surgeon’s preference for transsphincteric fistula-in-ano

Speciality: Colorectal

Chief Investigator: Professor David Jayne

Funded By: HTA     Portfolio Study ID: 9592

Phase: Phase III     

Initial Target Number of Patients: 500


HYMN: A randomised, controlled, phase III trial comparing hyperthermia plus mitomycin (HM) to a second course of bacillus Calmette-Guérin (BCG) or standard therapy in patients with recurrence of non-muscle invasive bladder cancer following induction or maintenance BCG therapy

Speciality: Bladder Cancer

Chief Investigator: Professor John Kelly

Funded By: CRUK     Portfolio Study ID: 6553

Phase: Phase III       

Initial Target Number of Patients: 242

PEGASUS-Logo 100 pixels wide

PEGASUS: A feasibility study and open pilot two-arm randomised controlled trial comparing Pressure Garment Therapy with no Pressure Garment Therapy for the prevention of abnormal scarring after burn injury (PEGASUS)

Speciality: Plastics

Chief Investigator: Mr Naiem Moiemen

Funded By: NIHR HTA     Portfolio Study ID: 17346

Phase: Pilot/Feasibility

Initial Target Number of Patients: 88



ROCSS:  Reinforcement of Closure of Stoma Site. A randomised controlled trial of reinforcement of closure of stoma site using a biological mesh

Speciality: Colorectal

Chief Investigator: Mr Aneel Bhangu

Funded By: LifeCell/RfPB     Portfolio Study ID: 13461

Phase: Phase III     

Initial Target Number of Patients: 90 


VITTAL: Viability Testing and Transplantation of Marginal Livers

Speciality: Liver Transplantation     

Chief Investigator: Professor Darius Mirza

 Funded By:  Wellcome Trust     Portfolio Study ID: 32299

 Phase:  Phase I/II    

Initial Target Number of Patients: 23